KIB OpenIR
Synthesis and Antitumor Activity of 1-Substituted 1,2,3-Triazole-Mollugin Derivatives
Luo,Han; Lv,Yong-Feng; Zhang,Hong; Hu,Jiang-Miao; Li,Hong-Mei; Liu,Shou-Jin
2021
发表期刊MOLECULES
ISSN1420-3049
卷号26期号:11页码:3249
摘要A new series of mollugin-1,2,3-triazole derivatives were synthesized using a copper(I)-catalyzed Huisgen 1,3-dipolar cycloaddition reaction of corresponding O-propargylated mollugin with aryl azides. All the compounds were evaluated for their cytotoxicity on five human cancer cell lines (HL-60, A549, SMMC-7721, SW480, and MCF-7) using MTS assays. Among the synthesized series, most of them showed cytotoxicity and most of all, compounds 14 and 17 exhibited significant cytotoxicity of all five cancer cell lines.
关键词mollugin triazoles antitumor activity synthesis ANTIMICROBIAL ACTIVITY RUBIA-CORDIFOLIA MOLLUGIN DESIGN ANALOGS BIOEVALUATION GLYCOSIDES APOPTOSIS AZIDES
DOI10.3390/molecules26113249
WOS记录号WOS:000660474600001
引用统计
文献类型期刊论文
条目标识符http://ir.kib.ac.cn/handle/151853/73454
专题中国科学院昆明植物研究所
作者单位1.[Luo, Han
2.Zhang, Hong
3.Anhui Univ Chinese Med, Coll Pharm, Hefei 230011, Peoples R China
4.[Lv, Yong-Feng
5.Hu, Jiang-Miao
6.Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming 650201, Yunnan, Peoples R China
推荐引用方式
GB/T 7714
Luo,Han,Lv,Yong-Feng,Zhang,Hong,et al. Synthesis and Antitumor Activity of 1-Substituted 1,2,3-Triazole-Mollugin Derivatives[J]. MOLECULES,2021,26(11):3249.
APA Luo,Han,Lv,Yong-Feng,Zhang,Hong,Hu,Jiang-Miao,Li,Hong-Mei,&Liu,Shou-Jin.(2021).Synthesis and Antitumor Activity of 1-Substituted 1,2,3-Triazole-Mollugin Derivatives.MOLECULES,26(11),3249.
MLA Luo,Han,et al."Synthesis and Antitumor Activity of 1-Substituted 1,2,3-Triazole-Mollugin Derivatives".MOLECULES 26.11(2021):3249.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Luo,Han]的文章
[Lv,Yong-Feng]的文章
[Zhang,Hong]的文章
百度学术
百度学术中相似的文章
[Luo,Han]的文章
[Lv,Yong-Feng]的文章
[Zhang,Hong]的文章
必应学术
必应学术中相似的文章
[Luo,Han]的文章
[Lv,Yong-Feng]的文章
[Zhang,Hong]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。